Jpmorgan Chase & Co »

Centessa Pharmaceuticals shares owned by Jpmorgan Chase & Co

Quarter-by-quarter ownership of Centessa Pharmaceuticals (CNTA) shares owned by Jpmorgan Chase & Co from 13F filings

Historical chart of Jpmorgan Chase & Co investment in Centessa Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Centessa Pharmaceuticals held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Centessa Pharmaceuticals by Jpmorgan Chase & Co

Quarter filed Position value Share count Share price at filing
2023-12-31 $85k 11k 7.96
2023-09-30 $65k 10k 6.47
2023-06-30 $367k 59k 6.19
2023-03-31 $382k 99k 3.85
2022-12-31 $39k 13k 3.06
2022-06-30 $875k 178k 4.90
2022-03-31 $42k 4.7k 8.99
2021-12-31 $52k 4.5k 11.42